Corbus Pharmaceuticals (CRBP) News Today $8.06 -0.30 (-3.59%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$8.06 0.00 (0.00%) As of 07/15/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRBP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors despite daily gainsJuly 15 at 6:42 AM | marketwatch.comCorbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedJuly 15 at 6:41 AM | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Buy" from BrokeragesJuly 7, 2025 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Above 50 Day Moving Average - Here's What HappenedJuly 4, 2025 | marketbeat.comCorbus Pharmaceuticals Reports No Neuropsychiatric Events in Phase 1 SAD Study of CRB-913, Advancing to MAD Portion - NasdaqJuly 2, 2025 | nasdaq.comCorbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with PembrolizumabJune 25, 2025 | globenewswire.comCorbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity SymposiumJune 24, 2025 | globenewswire.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Pass Above 50-Day Moving Average - Here's What HappenedJune 21, 2025 | marketbeat.comCorbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data?June 17, 2025 | seekingalpha.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Buy" from AnalystsJune 12, 2025 | marketbeat.comNuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)June 6, 2025 | marketbeat.comTwo Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)June 4, 2025 | marketbeat.comAnne Altmeyer Sells 1,392 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) StockJune 3, 2025 | marketbeat.comInsider Selling: Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Director Sells 2,783 Shares of StockJune 3, 2025 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Director Sells $10,092.00 in StockJune 3, 2025 | insidertrades.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLCMay 30, 2025 | marketbeat.comMizuho Securities Sticks to Its Buy Rating for Corbus Pharmaceuticals (CRBP)May 22, 2025 | theglobeandmail.comCorbus Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceMay 22, 2025 | globenewswire.comTang Capital Management LLC Has $2.86 Million Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)May 20, 2025 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Rating of "Buy" by AnalystsMay 20, 2025 | marketbeat.comCorbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board ChairMay 19, 2025 | finance.yahoo.comProsight Management LP Purchases 140,000 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)May 17, 2025 | marketbeat.comOrbimed Advisors LLC Raises Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)May 15, 2025 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLCMay 15, 2025 | marketbeat.comQ2 EPS Forecast for Corbus Pharmaceuticals Cut by AnalystMay 11, 2025 | marketbeat.comHC Wainwright Has Pessimistic Outlook of CRBP Q2 EarningsMay 11, 2025 | marketbeat.comQ2 EPS Estimates for Corbus Pharmaceuticals Cut by WedbushMay 11, 2025 | marketbeat.comQ2 Earnings Estimate for CRBP Issued By William BlairMay 11, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 160,933 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)May 10, 2025 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Given New $56.00 Price Target at OppenheimerMay 9, 2025 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Price Target Cut to $40.00 by Analysts at HC WainwrightMay 9, 2025 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Posts Earnings Results, Misses Expectations By $0.13 EPSMay 8, 2025 | marketbeat.comCorbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare ConferenceMay 8, 2025 | finance.yahoo.comCorbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 7, 2025 | finance.yahoo.comBoothbay Fund Management LLC Decreases Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)May 6, 2025 | marketbeat.comCorbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on TuesdayMay 1, 2025 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Bought by Renaissance Technologies LLCApril 29, 2025 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Consensus Rating of "Buy" by BrokeragesApril 25, 2025 | marketbeat.comAltium Capital Management LLC Raises Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)April 20, 2025 | marketbeat.comWe Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business GrowthApril 18, 2025 | finance.yahoo.comCorbus Pharmaceuticals management to meet with Piper SandlerApril 17, 2025 | markets.businessinsider.comCorbus announces first patient dosed in Phase 1 CRB-913 studyMarch 28, 2025 | markets.businessinsider.comCorbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of ObesityMarch 28, 2025 | globenewswire.comB. Riley Lifts Earnings Estimates for Corbus PharmaceuticalsMarch 17, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for CRBP EarningsMarch 17, 2025 | marketbeat.comWhat is B. Riley's Forecast for CRBP Q1 Earnings?March 15, 2025 | marketbeat.comWhat is Lifesci Capital's Estimate for CRBP Q1 Earnings?March 15, 2025 | marketbeat.comWedbush Reaffirms Outperform Rating for Corbus Pharmaceuticals (NASDAQ:CRBP)March 13, 2025 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Receives "Buy" Rating from HC WainwrightMarch 13, 2025 | marketbeat.comCorbus Pharmaceuticals (CRBP) Gets a Buy from RBC CapitalMarch 12, 2025 | markets.businessinsider.com Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address CRBP Media Mentions By Week CRBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBP News Sentiment▼0.850.97▲Average Medical News Sentiment CRBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBP Articles This Week▼33▲CRBP Articles Average Week Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TERN News ARCT News FULC News CKPT News AQST News HUMA News AMRN News PRTA News BNTC News HRTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
